Cardiovascular complications in pediatric end-stage renal disease

Pediatric Nephrology

Volumn 20, Issue 2, 2005, Pages 125-131

  Parekh, Rulan S ^a,d   Gidding, Samuel S ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d NONE   (United States)

Author keywords

Cardiovascular complications; End stage renal disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CYANOCOBALAMIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; PHOSPHATE BINDING AGENT; PYRIDOXINE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; HEART ARRHYTHMIA; HEART DILATATION; HEART INJURY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; KIDNEY FAILURE; NON INVASIVE MEASUREMENT; PATHOPHYSIOLOGY; PATIENT MONITORING; PEDIATRICS; PERICARDIAL DISEASE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ADOLESCENT; ADULT; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CHILD; HEALTH PLANNING GUIDELINES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; RISK ASSESSMENT; RISK FACTORS;

EID: 12944314760     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1664-0     Document Type: Review

References (51)

1. Parekh RS, Carroll CE, Wolfe RA, Port FK (2002) Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141:191-197 10.1067/mpd.2002.125910
2. Mitsnefes MM (2002) Pediatric end-stage renal disease: Heart as a target. J Pediatr 141:162-164 10.1067/mpd.2002.126921
3. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW (2003) Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:2154-2169 10.1161/01.CIR.0000095676.90936.80
4. Levin A, Thompson CR, Ethier J, Carlisle EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O (1999) Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kidney Dis 34:125-134 1:STN:280:DyaK1MzjtV2hsg%3D%3D
5. Alpert MA, Ravenscraft MD (2003) Pericardial involvement in end-stage renal disease. Am J Med Sci 325:228-236 12695728
6. Scharer K, Schmidt KG, Soergel M (1999) Cardiac function and structure in patients with chronic renal failure. Pediatr Nephrol 13:951-965 10.1007/s004670050737
7. Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Strife CF (2001) Changes in left ventricular mass in children and adolescents during chronic dialysis. Pediatr Nephrol 16:318-323 10.1007/s004670000557
8. Silverstein DM, Palmer J, Polinsky MS, Braas C, Conley SB, Baluarte HJ (2000) Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients. Pediatr Nephrol 14:105-110 10.1007/s004670050022
9. Kari JA, Vallance DT, Bruckdorfer KR, Leone A, Mullen MJ, Bunce T, Dorado B, Deanfield JE, Rees L (1997) Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 52:468-472 1:STN:280:ByiH3cbmsVY%3D
10. Fine A (2002) Relevance of C-reactive protein levels in peritoneal dialysis patients. Kidney Int 61:615-620 10.1046/j.1523-1755.2002.00145.x
11. Arici M, Walls J (2001) End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int 59:407-414 10.1046/j.1523-1755.2001.059002407.x
12. Querfeld U, Lang M, Friedrich JB, Kohl B, Fiehn W, Scharer K (1993) Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease. Pediatr Res 34:772-776 1:STN:280:ByuC2M7gslM%3D
13. Chavers BM, Li S, Collins AJ, Herzog CA (2002) Cardiovascular disease in pediatric chronic dialysis patients. Kidney Int 62:648-653 10.1046/j.1523-1755.2002.00472.x
14. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126 10.1056/NEJM199901143400207
15. Nayir A, Bilge I, Kilicaslan I, Ander H, Emre S, Sirin A (2001) Arterial changes in paediatric haemodialysis patients undergoing renal transplantation. Nephrol Dial Transplant 16:2041-2047
16. London G (2003) Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. J Am Soc Nephrol 14 [Suppl 4]:S305-S309
17. Milliner DS, Morgenstern BZ, Murphy M, Gonyea J, Sterioff S (1994) Lipid levels following renal transplantation in pediatric recipients. Transplant Proc 26:112-114 1:STN:280:ByuC2M7os10%3D
18. Litwin M, Grenda R, Prokurat S, Abuauba M, Latoszynska J, Jobs K, Boguszewska-Baczkowska A, Wawer ZT (2001) Patient survival and causes of death on hemodialysis and peritoneal dialysis - single-center study. Pediatr Nephrol 16:996-1001 10.1007/s004670100012
19. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483 10.1056/NEJM200005183422003
20. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100-105 10.1161/01.CIR.0000020222.63035.C0
21. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K (2002) Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61:638-647 10.1046/j.1523-1755.2002.00170.x
22. Moe SM, Duan D, Doehle BP, O'Neill KD, Chen NX (2003) Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 63:1003-1011 10.1046/j.1523-1755.2003.00820.x
23. Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2003) Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107:864-868 10.1161/01.CIR.0000049744.23613.69
24. Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF (2000) Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:898-902 10.1007/s004670000303
25. Ulmer H (1978) Cardiovascular impairment and physical working capacity in children with chronic renal failure. Acta Paediatr Scand 67:43-48 1:STN:280:CSeC38%2FksVI%3D
26. Morris KP, Skinner JR, Wren C, Hunter S, Coulthard MG (1993) Cardiac abnormalities in end stage renal failure and anaemia. Arch Dis Child 68:637-643 1:STN:280:ByyA3M3gsF0%3D
27. Litwin M, Kawalec W, Latoszynska J, Grenda R, Smirska E (1994) Cardiac systolic and diastolic function in children on hemodialysis and continuous ambulatory peritoneal dialysis. Contrib Nephrol 106:114-118 1:STN:280:ByuB38fotV0%3D
28. Johnstone LM, Jones CL, Grigg LE, Wilkinson JL, Walker RG, Powell HR (1996) Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int 50:998-1006 1:STN:280:ByiD38nnvFw%3D
29. Mitsnefes M, Ho PL, McEnery PT (2003) Hypertension and progression of chronic renal insufficiency in children: A Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol 14:2618-2622 10.1097/01.ASN.0000089565.04535.4B
30. Neu AM, Ho PL, McDonald RA, Warady BA (2002) Chronic dialysis in children and adults. The 2001NAPRTCS Annual Report. Pediatr Nephrol 17:656-663 10.1007/s00467-002-0928-9
31. Parekh RS, Ni W, Fivush BA, Klag MJ (2001) Prevalence of traditional cardiovascular risk factors in the Dialysis Mortality and Morbidity Special Study (DMMS) among different age groups: A nationally representative sample of the US ESRD population. J Am Soc Nephrol 12:236A 10.1159/000051264
32. National Kidney Foundation (2003) K/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 41 [Suppl 3]:S1-S92
33. Bostom AG, Kronenberg F, Jacques PF, Kuen E, Ritz E, Konig P, Kraatz G, Lhotta K, Mann JF, Muller GA, Neyer U, Riegel W, Schwenger V, Riegler P, Selhub J (2001) Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate. Atherosclerosis 159:219-223 10.1016/S0021-9150(01)00502-0
34. Merouani A, Lambert M, Delvin EE, Genest J Jr, Robitaille P, Rozen R (2001) Plasma homocysteine concentration in children with chronic renal failure. Pediatr Nephrol 16:805-811 10.1007/s004670100648
35. Lilien M, Duran M, Van Hoeck K, Poll-The BT, Schroder C (1999) Hyperhomocyst(e)inaemia in children with chronic renal failure. Nephrol Dial Transplant 14:366-368
36. Stenvinkel P, Pecoits-Filho R, Lindholm B (2003) Coronary artery disease in end-stage renal disease: No longer a simple plumbing problem. J Am Soc Nephrol 14:1927-1939 10.1097/01.ASN.0000069165.79509.42
37. Goldstein SL, Currier H, Watters L, Hempe JM, Sheth RD, Silverstein D (2003) Acute and chronic inflammation in pediatric patients receiving hemodialysis. J Pediatr 143:653-657 10.1067/S0022-3476(03)00534-1
38. Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31:607-617 1:STN:280:DyaK1c7ovFKlsw%3D%3D
39. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK (2001) Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131-2138 1:CAS:528:DC%2BD3MXnsFWiurk%3D
40. Gidding SS (2002) The aging of the cardiovascular system: When should children be treated like adults? J Pediatr 141:159-161 10.1067/mpd.2002.126922
41. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996) The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28:53-61 1:STN:280:BymA3M3jvFQ%3D
42. McGill HC Jr, McMahan CA (2003) Starting earlier to prevent heart disease. JAMA 290:2320-2322 10.1001/jama.290.17.2320
43. Aggoun Y, Niaudet P, Laffont A, Sidi D, Kachaner J, Bonnet D (2000) Cardiovascular impact of end-stage renal insufficiency in children undergoing hemodialysis. Arch Mal Coeur Vaiss 93:1009-1013 1:STN:280:DC%2BD3cvkt1ygsQ%3D%3D
44. Hampl H, Sternberg C, Berweck S, Lange D, Lorenz F, Pohle C, Riedel E, Gogoll L, Hennig L (2002) Regression of left ventricular hypertrophy in hemodialysis patients is possible. Clin Nephrol 58 [Suppl 1]:S73-S96
45. Shaddy RE, Tani LY, Gidding SS, Pahl E, Orsmond GS, Gilbert EM, Lemes V (1999) Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: A multi-institutional experience. J Heart Lung Transplant 18:269-274
46. National Cholesterol Education Program (1992) Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 89:525-584 1538956
47. American Diabetes Association (2003) Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care 26:2194-2197 12832334
48. Group KDOQIKD (2003), K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 41 [Suppl 3]:S1-S91
49. Kasiske B, Cosio FG, Beto J, Bolton K, Chavers BM, Grimm R Jr, Levin A, Masri B, Parekh R, Wanner C, Wheeler DC, Wilson PW (2004) Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: A report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant 4 [Suppl 7]:13-53
50. Bennett-Richards K, Kattenhorn M, Donald A, Oakley G, Varghese Z, Rees L, Deanfield JE (2002) Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation 105:1810-1815 10.1161/01.CIR.0000014417.95833.1D
51. Bostom AG, Kronenberg F, Gohh RY, Schwenger V, Kuen E, Konig P, Kraatz G, Lhotta K, Mann JF, Muller GA, Neyer U, Riegel W, Riegler P, Ritz E, Selhub J (2001) Chronic renal transplantation: A model for the hyperhomocysteinemia of renal insufficiency. Atherosclerosis 156:227-230 10.1016/S0021-9150(00)00613-4